Pinnacle Wealth Planning Services »

BioCryst Pharmaceuticals shares owned by Pinnacle Wealth Planning Services

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Pinnacle Wealth Planning Services from 13F filings

Historical chart of Pinnacle Wealth Planning Services investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Pinnacle Wealth Planning Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Pinnacle Wealth Planning Services

Quarter filed Position value Share count Share price at filing
2024-09-30 $188k 25k 7.60
2024-06-30 $142k 23k 6.18
2023-12-31 $123k 21k 5.99
2020-12-31 $999 143 6.99

More positions owned by Pinnacle Wealth Planning Services

Vaneck Ig Floating Rate Etf Etf (FLTR)
Energy Transfer Equity L P Com Unit Ltd Partnership Stock (ET)
Spdr Portfolio S&p 600 Small Cap Etf Etf (SPSM)
Spdr Portfolio S&p 500 Value Etf Etf (SPYV)
Apple Stock (AAPL)
Microsoft Stock (MSFT)
Spdr Portfolio Aggregate Bond Etf Etf (SPAB)
Nvidia Corp Stock (NVDA)
Spdr Portfolio S&p 500 Growth Etf Etf (SPYG)
Amazon.com Stock (AMZN)
Spdr Portfolio S&p 500 Etf Etf (SPLG)
Spdr Doubleline Emerging Markets Fixed Income Etf Etf (EMTL)
Meta Platforms Inc Cl A Stock (META)
Ishares Msci Eafe Value Index Etf Etf (EFV)
Google Stock (GOOGL)

View all positions for Pinnacle Wealth Planning Services

Top funds holding BioCryst Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Kynam Capital Management
Deerfield Management Company
Geode Capital Management
Nuveen Asset Management
RP Management
Rock Springs Capital Management
Fisher Investments
Jennifer Ranahan
Caligan Partners
Goldman Sachs Group
T. Rowe Price Associates

View all funds holding BioCryst Pharmaceuticals